Purpose: To compare the efficacy of nepafenac 0.3% with nepafenac 0.1% to control postoperative pain and conjunctival redness after cataract surgery. Study Design: Randomized control trial Place and Duration: Ophthalmology Department, DHQ Teaching Hospital, Gujranwala from November 2020 to January 2021. Materials and Methods: A prospective review of 70 patients operated for age-related cataract was done. Patients were divided into two equal groups. Group A patients were given Ilevro eye drops (nepafenac 0.3%) once a day and group B patients were instilled Nevanac eye drops (nepafenac 0.1%) thrice a day. All patients were scored for ocular pain and conjunctival redness on basis of pre-defined scales on one day before surgery and on 1st, 7th and 14th postoperative day. Results from both groups were analyzed and compared using SPSS v 25.0. Results: Out of 70 patients, 35 were put in group A and 35 into group B. Overall 37 (52.8%) patients were male and 33 (47.2%) were female. Patients above 40 years of age were 33 (94.3%) in group A and 35 (100%) in group B. Patients having pain score ≥5 were 30 (85.7%) in group A and 25 (71.4%) in group B on 1st postoperative day, with ≥3 were 1 (2.8%) in group A and 33 (94.2%) in group B at 7th postoperative day and zero on 14th postoperative day. Patients with conjunctival redness ≥2 were 31 (88.6%) in group A and 29 (82.9%) in group B on 1st postoperative day, with ≥1 were 18 (51.3%) in group A and 28 (79.9%) in group B on 7th postoperative day while four (11.4%) in group A and one (2.8%) in group B on 14th postoperative day.   Conclusion: Effect of once daily nepafenac 0.3% on postoperative pain and conjunctival redness was found to be sub-rated against thrice daily nepafenac 0.1% on 1st postoperative day. However, this effect became equal and then slightly superior to that of nepafenac 0.1% on 7th and 14th postoperative days. Key Words: Cataract Surgery, Nepafenac, Postoperative Pain, Conjunctival Redness

Purpose:  To determine the factors that cause delay in Dacryocystorhinostomy in patients with chronic dacryocystitis. Study Design:  Cross sectional survey. Place and Duration of Study:  Ophthalmology Department DHQ Teaching Hospital Gujranwala from February 2021 to May 2021 Methods:  Sixty five ophthalmologists were included in this study. Questionnaire was designed on Google Forms and it composed of four parts. First part included the title and purpose of this study. Second part included professional information regarding qualification and place of practice. Third part included 18 questions that were divided in three sub-sections in terms of factors related to the patient (5 questions), ophthalmologist (9 questions), and health resources provided (4 questions). Responses were recorded in yes/no answers.  Last part comprised of blank space for remarks. The electronic link of questionnaire was shared with the participants of ophthalmology educational groups on WhatsApp, Facebook and E-mail. Data was analyzed using SPSS 23.00 software and results were derived based on questionnaire. Results:  Out of 65 ophthalmologists, 48 (72.7%) agreed that patients suffered from delay in surgical management. Among the hospital related factors, 45 (69.23%) ophthalmologists believe that busy Out patient department accounted for most of the delay. Among patient related factors, 51 (78.46%) ophthalmologists were of the view that patients took the disease lightly as it was not vision-threating. Forty one ophthalmologists (63.07%) reported that there was lack of surgical exposure during training years to learn DCR. Conclusion:  There are various patient related, surgeon related and hospital related factors which play a significant role in delay of surgical management of chronic dacryocystitis. Key Words:  Dacryocystitis, Dacryocystorhinostomy, Epiphora.